Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19.
Mendez, Sean R. MD a; Frank, Rachel C. MD b; Stevenson, Elizabeth K. MD e; Chung, Mabel MD, MPH c,d,f; Silverman, Michael G. MD, MPH b,d
[Letter] Chest. 160(1):89-93, July 2021.

(Format: HTML, PDF)